The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Patou Gary since 2005.
This trader's CIK number is 1283535.
At the time of last reporting, Patou Gary was the Officer of Xenon Pharmaceuticals Inc.. (stock ticker symbol XENE).
Also see all insider trading activities at Xenon Pharmaceuticals Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | XENE | 0 | $0 | 4,891 | $200,922 | 6,586 | $68,691 |
| 2023 | XENE | 0 | $0 | 18,978 | $754,052 | 14,402 | $137,783 |
| 2022 | XENE | 0 | $0 | 3,994 | $138,000 | 2,057 | $5,512 |
| 2021 | XENE | 0 | $0 | 0 | $0 | 2,057 | $7,549 |
| 2020 | XENE | 0 | $0 | 0 | $0 | 2,057 | $7,734 |
| 2019 | XENE | 0 | $0 | 0 | $0 | 2,057 | $7,322 |
| 2018 | XENE | 0 | $0 | 0 | $0 | 10,287 | $36,765 |
| 2017 | XENE | 12,500 | $35,840 | 0 | $0 | 0 | $0 |
| 2016 | XENE | 0 | $0 | 0 | $0 | 12,345 | $39,627 |
| 2015 | XENE | 0 | $0 | 0 | $0 | 6,994 | $35,669 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2006 | OSCI | 0 | $0 | 305,919 | $583,358 | 0 | $0 |
| 2005 | OSCI | 0 | $0 | 500 | $1,025 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2014 | PCRX | 0 | $0 | 79,700 | $6,827,976 | 80,000 | $452,960 |
| 2013 | PCRX | 0 | $0 | 100,000 | $3,304,450 | 100,000 | $161,000 |
1. Xenon Pharmaceuticals Inc. (XENE)
2. Oscient Pharmaceuticals Corp (OSCI)
3. Pacira Biosciences, Inc. (PCRX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-11-22 | XENE | Sale | 4,891 | 41.08 | 200,922 |
| 2024-11-22 | XENE | Option Ex | 6,586 | 10.43 | 68,691 |
| 2023-12-13 | XENE | Option Ex | 14,402 | 9.57 | 137,783 |
| 2023-12-13 | XENE | Sale | 18,978 | 39.73 | 754,052 |
| 2022-11-25 | XENE | Sale | 1,937 | 34.79 | 67,390 |
| 2022-11-25 | XENE | Option Ex | 2,057 | 2.68 | 5,512 |
| 2022-11-23 | XENE | Sale | 2,057 | 34.33 | 70,610 |
| 2021-12-08 | XENE | Option Ex | 2,057 | 3.67 | 7,549 |
| 2020-10-28 | XENE | Option Ex | 2,057 | 3.76 | 7,734 |
| 2019-12-04 | XENE | Option Ex | 2,057 | 3.56 | 7,322 |
| 2018-12-14 | XENE | Option Ex | 2,057 | 3.07 | 6,314 |
| 2018-06-14 | XENE | Option Ex | 8,230 | 3.70 | 30,451 |
| 2017-08-10 | XENE | Buy | 7,500 | 2.78 | 20,835 |
| 2017-08-08 | XENE | Buy | 5,000 | 3.00 | 15,005 |
| 2016-12-06 | XENE | Option Ex | 12,345 | 3.21 | 39,627 |
| 2015-11-04 | XENE | Option Ex | 3,497 | 5.22 | 18,254 |
| 2015-01-07 | XENE | Option Ex | 3,497 | 4.98 | 17,415 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2006-05-31 | OSCI | Sale | 20,000 | 1.26 | 25,200 |
| 2006-05-22 | OSCI | Sale | 30,000 | 1.33 | 39,900 |
| 2006-05-22 | OSCI | Sale | 30,000 | 1.33 | 39,900 |
| 2006-04-25 | OSCI | Sale | 25,000 | 1.75 | 43,750 |
| 2006-04-26 | OSCI | Sale | 25,000 | 1.71 | 42,750 |
| 2006-03-30 | OSCI | Sale | 10,000 | 1.98 | 19,800 |
| 2006-03-20 | OSCI | Sale | 20,000 | 2.09 | 41,800 |
| 2006-03-21 | OSCI | Sale | 10,000 | 2.15 | 21,500 |
| 2006-03-03 | OSCI | Sale | 10,000 | 2.10 | 21,000 |
| 2006-03-03 | OSCI | Sale | 10,000 | 2.10 | 21,000 |
| 2006-02-27 | OSCI | Sale | 10,000 | 1.93 | 19,300 |
| 2006-02-10 | OSCI | Sale | 15,000 | 2.10 | 31,500 |
| 2006-02-07 | OSCI | Sale | 25,000 | 2.29 | 57,250 |
| 2006-01-27 | OSCI | Sale | 10,000 | 2.15 | 21,500 |
| 2006-01-12 | OSCI | Sale | 10,000 | 2.50 | 25,000 |
| 2006-01-09 | OSCI | Sale | 30,919 | 2.52 | 78,008 |
| 2006-01-03 | OSCI | Sale | 15,000 | 2.28 | 34,200 |
| 2005-04-26 | OSCI | Sale | 500 | 2.05 | 1,025 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-08-07 | PCRX | Option Ex | 20,000 | 7.40 | 147,960 |
| 2014-08-07 | PCRX | Sale | 20,000 | 100.26 | 2,005,200 |
| 2014-07-14 | PCRX | Sale | 29,700 | 87.25 | 2,591,176 |
| 2014-07-14 | PCRX | Option Ex | 30,000 | 5.97 | 179,100 |
| 2014-05-09 | PCRX | Option Ex | 20,000 | 3.55 | 71,000 |
| 2014-05-09 | PCRX | Sale | 20,000 | 74.08 | 1,481,600 |
| 2014-05-12 | PCRX | Option Ex | 10,000 | 5.49 | 54,900 |
| 2014-05-12 | PCRX | Sale | 10,000 | 75.00 | 750,000 |
| 2013-10-01 | PCRX | Option Ex | 20,000 | 1.61 | 32,200 |
| 2013-10-01 | PCRX | Sale | 20,000 | 48.92 | 978,400 |
| 2013-07-01 | PCRX | Option Ex | 30,000 | 1.61 | 48,300 |
| 2013-07-02 | PCRX | Option Ex | 10,000 | 1.61 | 16,100 |
| 2013-07-01 | PCRX | Sale | 30,000 | 29.25 | 877,500 |
| 2013-07-02 | PCRX | Sale | 10,000 | 30.00 | 300,000 |
| 2013-04-12 | PCRX | Option Ex | 10,000 | 1.61 | 16,100 |
| 2013-04-12 | PCRX | Sale | 10,000 | 30.00 | 300,000 |
| 2013-04-01 | PCRX | Sale | 30,000 | 28.29 | 848,550 |
| 2013-04-01 | PCRX | Option Ex | 30,000 | 1.61 | 48,300 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Patou Gary (Officer of Xenon Pharmaceuticals Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.